Tyr314

Site Information
VAQPkEVyRQQQQQQ SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 465176

In vivo Characterization
Methods used to characterize site in vivo:	immunoprecipitation ( 1 ) , mass spectrometry ( 1 , 2 )
Disease tissue studied:	lung cancer ( 1 , 2 )
Relevant cell line - cell type - tissue:	CL1-5 (pulmonary) ( 1 ) , lung ( 2 )

References
1	Wu HY, et al. (2009) Combining alkaline phosphatase treatment and hybrid linear ion trap/Orbitrap high mass accuracy liquid chromatography-mass spectrometry data for the efficient and confident identification of protein phosphorylation. Anal Chem 81, 7778-87 19702290 Curated Info
2	Guo A (2006) CST Curation Set: 1151; Year: 2006; Biosample/Treatment: tissue, lung/-; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991 Curated Info